Clinical Trial Update: PXVX0200 (CVD103-HgR) vs Shanchol in Mali [Phase 2]

View source ↗

Summary

Phase 2 trial comparing PXVX0200 (CVD103-HgR) to Shanchol for cholera has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholera

Drugs mentioned

• PXVX0200 (CVD103-HgR) (CVD103-HgR)
• Shanchol (oral cholera vaccine)

Snippet

Sponsor: University of Maryland, Baltimore | Conditions: Cholera | Phase 2 | Status: COMPLETED